| Orders | Qty | Bid |
|---|---|---|
| 1 | 1 | 3479.4 |
| 1 | 1 | 3479.2 |
| 2 | 8 | 3479 |
| 2 | 4 | 3478.9 |
| 1 | 1 | 3478.8 |
| Ask | Qty | Orders |
|---|---|---|
| 3482.1 | 1 | 1 |
| 3482.2 | 2 | 3 |
| 3482.3 | 1 | 1 |
| 3482.4 | 1 | 1 |
| 3482.9 | 2 | 2 |

Ajanta Pharma Ltd has delivered a 148.01% absolute return over the past 5 years, equivalent to a CAGR of 19.92% per annum. The stock was priced at ₹1,424.70 in Sep 2021 and has risen to ₹3,533.40 as of 12 Sep 2026. An investment of ₹1,00,000 in Ajanta Pharma Ltd five years ago would be worth ₹2,48,010.00 today.
The all-time high (ATH) for Ajanta Pharma Ltd was ₹3,718.20, recorded on 17 Aug 2026. At the current price of ₹3,533.40, the stock is trading 4.97% below its all-time high. The all-time low recorded was ₹10.23 on 06 Jan 2010.
Yes,Ajanta Pharma Ltd has declared a consistent dividend every year over the past 5 years. The company paid a total dividend of 146.00 per share between FY2022 and FY2026, with the most recent dividend of ₹32.00 per share for Jul 26, with an ex-dividend date of 05 Aug 2026. At the current market price of ₹3,533.40, the trailing dividend yield of Ajanta Pharma Ltd stands at 60.00%.
The intraday low for Ajanta Pharma Ltd on the NSE today was ₹3,425.00. The stock's 52-week low stands at ₹2,329.90, recorded on 30 Sep 2025. Today's low is 47.00% above the 52-week low, indicating the stock is trading well above its yearly lows.
Ajanta Pharma Ltd has delivered 37.00% return over the last 52 weeks. During this period, the stock hit a 52-week high of ₹3,796.00 on 18 Aug 2026 and a 52-week low of ₹2,329.90 on 30 Sep 2025. It is currently trading at ₹3,533.40 as of 12 Sep 2026.
As of 12 Sep 2026, the share price of Ajanta Pharma Ltd is ₹3,533.40 on the NSE and ₹3,537.05 on the BSE. The stock opened at ₹3,516.00, touched a high of ₹3,666.90 and a low of ₹3,425.00 during today's session.
Over the last 6 months, Ajanta Pharma Ltd has given a return of 13.27%. The stock was priced at ₹3,119.50 on 12 Mar 2026 and has Rise to ₹3,533.40 as of 12 Sep 2026, a change of ₹413.90 per share.
For Q1 FY27, Ajanta Pharma Ltd reported: Revenue (Net Sales): ₹15391.40 Cr - Up 22.48% year-on-year from ₹12566.90 Cr in Q4 FY26. Net Income (PAT): ₹3154.70 Cr - Up 59.91% year-on-year from ₹1972.80 Cr in Q4 FY26.
Ajanta Pharma Ltd has delivered a return of 12.85% over the last 3 months. The stock was trading at ₹3,131.00 on 12 Jun 2026 and is currently at ₹3,533.40 as of 12 Sep 2026, reflecting a Gain of ₹402.40 per share over this period.
The intraday high for Ajanta Pharma Ltd on the NSE today (12 Sep 2026) was ₹3,666.90. This compares to the 52-week high of ₹3,796.00 recorded on 18 Aug 2026. Today's high was -3.40% below the 52-week high.